NeoGenomics and German Breast Group Announce New Data Demonstrating Clinical Potential of the RaDaR MRD Assay in HR+/HER2- Breast Cancer
Press Release
Read More
NeoGenomics to Participate at the Goldman Sachs 44th Annual Global Healthcare Conference
Press Release
Read More
NeoGenomics to Showcase the Transformational Impact of RaDaR(R) Assay for Molecular Residual Disease and Recurrence Monitoring at ASCO
Press Release
Read More
NeoGenomics to Participate at the BofA Securities 2023 Healthcare Conference
Press Release
Read More
Spatial Analysis of Genomic Signatures on Colorectal Cancer Pathogenesis Using the NanoString GeoMx® Digital Spatial Profiler
Literature
Read More
Bridging the gap between targeted NGS and FISH gene-level CNV detection capabilities in hematologic malignancies
Literature
Read More